Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis
- PMID: 27575911
- DOI: 10.1164/rccm.201604-0893OC
Comparison of Lung Clearance Index and Magnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis
Abstract
Rationale: Early onset and progression of lung disease in children with cystic fibrosis (CF) indicates that sensitive noninvasive outcome measures are needed for diagnostic monitoring and early intervention clinical trials. The lung clearance index (LCI) and chest magnetic resonance imaging (MRI) were shown to detect early lung disease in CF; however, the relationship between the two measures remains unknown.
Objectives: To correlate the LCI with abnormalities detected by MRI and compare the sensitivity of the two techniques to detect responses to therapy for pulmonary exacerbations in children with CF.
Methods: LCI determined by age-adapted multiple breath washout techniques and MRI studies were performed in 97 clinically stable children with CF across the pediatric age range (0.2-21.1 yr). Furthermore, LCI (n = 26) or MRI (n = 10) were performed at the time of pulmonary exacerbation and after antibiotic therapy. MRI was evaluated using a dedicated morphofunctional score.
Measurements and main results: The LCI correlated with the global MRI score as well as MRI-defined airway wall abnormalities, mucus plugging, and abnormal lung perfusion in infants and toddlers (P < 0.05 to P < 0.001) and in older children (P < 0.001) with CF. LCI and MRI were sensitive to detect response to antibiotic therapy for pulmonary exacerbations.
Conclusions: Our results indicate that LCI and MRI may be useful complementary tools for noninvasive monitoring and as quantitative endpoints in early intervention trials in children with CF. In this context, MRI enables detection of disease heterogeneity, including regional mucus plugging associated with abnormal lung perfusion in early CF lung disease. Clinical trial registered with www.clinicaltrials.gov (NCT 02270476).
Trial registration: ClinicalTrials.gov NCT02270476.
Keywords: cystic fibrosis; lung clearance index; lung disease; magnetic resonance imaging; noninvasive monitoring.
Comment in
-
How Best to Capture Early Cystic Fibrosis Lung Disease?Am J Respir Crit Care Med. 2017 Feb 1;195(3):283-284. doi: 10.1164/rccm.201609-1836ED. Am J Respir Crit Care Med. 2017. PMID: 28145764 No abstract available.
-
The Respective Roles of Lung Clearance Index and Magnetic Resonance Imaging in the Clinical Management of Patients with Cystic Fibrosis.Am J Respir Crit Care Med. 2018 Feb 1;197(3):409. doi: 10.1164/rccm.201706-1137LE. Am J Respir Crit Care Med. 2018. PMID: 28800245 No abstract available.
-
Reply to Verbanck and Vanderhelst: The Respective Roles of Lung Clearance Index and Magnetic Resonance Imaging in the Clinical Management of Patients with Cystic Fibrosis.Am J Respir Crit Care Med. 2018 Feb 1;197(3):410-411. doi: 10.1164/rccm.201707-1367LE. Am J Respir Crit Care Med. 2018. PMID: 28800247 No abstract available.
Similar articles
-
Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.Am J Respir Crit Care Med. 2014 Apr 15;189(8):956-65. doi: 10.1164/rccm.201309-1659OC. Am J Respir Crit Care Med. 2014. PMID: 24564281
-
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.Thorax. 2008 Feb;63(2):129-34. doi: 10.1136/thx.2007.077784. Epub 2007 Aug 3. Thorax. 2008. PMID: 17675316
-
Comparison of lung clearance index determined by washout of N2 and SF6 in infants and preschool children with cystic fibrosis.J Cyst Fibros. 2019 May;18(3):399-406. doi: 10.1016/j.jcf.2018.11.001. Epub 2018 Nov 9. J Cyst Fibros. 2019. PMID: 30420236
-
Lung clearance index in the assessment of airways disease.Respir Med. 2009 Jun;103(6):793-9. doi: 10.1016/j.rmed.2009.01.025. Epub 2009 Feb 25. Respir Med. 2009. PMID: 19246184 Review.
-
The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic?Curr Opin Pulm Med. 2018 Nov;24(6):579-585. doi: 10.1097/MCP.0000000000000515. Curr Opin Pulm Med. 2018. PMID: 30095491 Review.
Cited by
-
The established chest MRI score for cystic fibrosis can be applied to contrast agent-free matrix pencil decomposition functional MRI: a multireader analysis.Front Med (Lausanne). 2025 Mar 18;12:1527843. doi: 10.3389/fmed.2025.1527843. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40171501 Free PMC article.
-
[Management of Primary Ciliary Dyskinesia].Pneumologie. 2020 Nov;74(11):750-765. doi: 10.1055/a-1235-1520. Epub 2020 Sep 25. Pneumologie. 2020. PMID: 32977348 Free PMC article. Review. German.
-
Novel imaging techniques for cystic fibrosis lung disease.Pediatr Pulmonol. 2021 Feb;56 Suppl 1(Suppl 1):S40-S54. doi: 10.1002/ppul.24931. Pediatr Pulmonol. 2021. PMID: 32592531 Free PMC article. Review.
-
Contrast agent-free functional magnetic resonance imaging with matrix pencil decomposition to quantify abnormalities in lung perfusion and ventilation in patients with cystic fibrosis.Front Med (Lausanne). 2024 Jun 5;11:1349466. doi: 10.3389/fmed.2024.1349466. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38903825 Free PMC article.
-
Question 3: Can we diagnose asthma in children under the age of 5 years?Paediatr Respir Rev. 2019 Feb;29:25-30. doi: 10.1016/j.prrv.2018.10.003. Epub 2018 Oct 24. Paediatr Respir Rev. 2019. PMID: 30528365 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical